Navigation Links
Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
Date:11/1/2013

Toronto, Canada (PRWEB) November 01, 2013

The conduct of clinical trials has increasingly become globalised and expanded well beyond the traditional regions of North America and Western Europe. Global trials now typically include centers based in Asia, Central and Eastern Europe, Central and South America and the Middle East. This globalization is the result of a number of significant advantages over limiting trials to traditional locations. These advantages include access to greater numbers of patients and hence faster recruitment, brand exposure to more markets, cost efficiencies and access to patient populations to facilitate marketing approvals in various countries.

This webinar will address in more detail the advantages of globalization as well as the best practices for overcoming the challenges.

A Q&A with the audience will follow the main presentation.

To learn more about the presentation or register to attend, visit: http://xtalks.com/globalizing-clinical-trials.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Michelle Tran, Marketing Manager
+1 (416) 977-6555 ext 284
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. SureClinical Announces SurePortal™, First 100% Paperless eTMF Investigator Portal for Automated Document Completion Across Mobile, Web
2. Star Scientific and Rock Creek Pharmaceuticals Announce the Publication of a Peer-Reviewed Article about the ASAP Clinical Trial Showing Immune System Support in Hashimotos Thyroiditis
3. Formedix Partners With OpenClinica to Deliver Automated End-to-End Clinical Trial Builds
4. Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
5. Inflamax Research, Inc. Announces Fully-Integrated Clinical e-Source Data Management Services
6. Micropharma completes development of first microbiome clinical lab test using digital PCR technology
7. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
8. Harvard researchers, pharma experts offer recommendations to expand access to clinical trial data
9. Syneron Medical Completes and Summarizes the Multi-site Clinical Study Agreed Upon with FDA for the UltraShape Contour I
10. WIRB-Copernicus Group Leaders Speak at Global Clinical Research Summit in South Korea
11. QuickSTAT “Cold Chain Manager” Technology Solution Ensures Temperature Integrity for Clinical Trial and Drug Development Shipments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Actavis plc (NYSE: ... and Rhythm, a biopharmaceutical company, today announced that Actavis ... wholly owned subsidiary, Rhythm Health, Inc., which is developing ... of diabetic gastroparesis and other GI functional disorders. ... trial of relamorelin for the treatment of diabetic gastroparesis ...
(Date:10/22/2014)... Involution Studios , a healthcare software design ... Understanding Ebola . The goal of the ... follow informative tool for anyone wanting to know more ... , "As the news has spread in all directions ... not only a healthcare crisis with global impact, but ...
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
... marine scientists from across the world have issued a ... offsets from ocean iron fertilisation. , Published on Friday ... US, Japan, Hawaii, New Zealand, The Netherlands, India, Germany ... Andrew Watson of the University of East Anglia and ...
... 10 BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) ... as a consultant and interim Chief Medical Officer. ... in global pharmaceutical,development to his position at BioCryst., ... are very pleased to have Tom join BioCryst ...
... News, Va. Also ... Recognized, CHICAGO, ... achievements in its,community, Harborview Medical Center of Seattle is the recipient of ... esteemed,honors of excellence in community service in healthcare. As one of two,primary ...
Cached Biology Technology:BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 2BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 3BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 4Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 2Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 3Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 4Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 5Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 6
(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... non-traditional biophysics textbook and it describes how life functions ... discovery into biological systems and provides an understanding of ... about how our genes make proteins that control the ... in an organism. It quantifies the principles of life ... found on both large and small scales. The book ...
(Date:10/15/2014)... SHELTON, Conn. , Oct. 15, 2014 NXT-ID, Inc. ... a biometric authentication company focused on the growing mobile commerce market ... NASDAQ MarketSite in Times Square on Monday October 13 th . ... with CTO David Tunnel and angel investor Mr. ... Gino Pereira , CEO of NXT-ID thanked his investors and employees ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2New book about life as seen from physics 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
... Digging into Data Challenge was announced by four ... (JISC) from the United Kingdom, the National Endowment ... Foundation (NSF) from the United States, and the ... Canada. The Digging into Data ...
... a greater rate than other places in the Northern ... future. As a result, glacier and ice-sheet melting, ... be expected to continue. A new comprehensive scientific ... time the pervasive nature of Arctic climate amplification. ...
... 12, 2009 The 2009 winners of the National ... M.D. and Lee Goodglick, Ph.D. The $100,000 grants will ... the role of estrogen in lung cancer tumors, respectively. ... lung cancer at Memorial Sloan-Kettering Cancer Center in New ...
Cached Biology News:Leading research agencies announce new international competition: "The digging into data challenge" 2Arctic heats up more than other places 2National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients 2
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
...
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer...
... Clean spin filters allow for the rapid isolation ... your DNA gel slice in the spin filter, ... your DNA is recovered. There is no need ... buffers. Spin filters can also be used for ...
Biology Products: